Lodie T - Search Results

1

Harnessing regulatory T cells to establish immune tolerance.

Ho P, Cahir-McFarland E, Fontenot JD, Lodie T, Nada A, Tang Q, Turka LA, Bluestone JA. Ho P, et al. Among authors: lodie t. Sci Transl Med. 2024 Mar 13;16(738):eadm8859. doi: 10.1126/scitranslmed.adm8859. Epub 2024 Mar 13. Sci Transl Med. 2024. PMID: 38478632 Review.

2

VEGFR1 stimulates a CXCR4-dependent translocation of megakaryocytes to the vascular niche, enhancing platelet production in mice.

Pitchford SC, Lodie T, Rankin SM. Pitchford SC, et al. Among authors: lodie t. Blood. 2012 Oct 4;120(14):2787-95. doi: 10.1182/blood-2011-09-378174. Epub 2012 May 31. Blood. 2012. PMID: 22653973 Free article.

3

Immunomodulatory activity of mesenchymal stem cells.

Kaplan JM, Youd ME, Lodie TA. Kaplan JM, et al. Among authors: lodie ta. Curr Stem Cell Res Ther. 2011 Dec;6(4):297-316. doi: 10.2174/157488811797904353. Curr Stem Cell Res Ther. 2011. PMID: 21190531 Review.

4

A changing time: the International Society for Cellular Therapy embraces its industry members.

Deans R, Gunter KC, Allsopp T, Bonyhadi M, Burger SR, Carpenter M, Clark T, Cox CS, Driscoll D, Field E, Huss R, Lardenoije R, Lodie TA, Mason C, Neubiser R, Rasko JE, Rowley J, Maziarz RT. Deans R, et al. Among authors: lodie ta. Cytotherapy. 2010 Nov;12(7):853-6. doi: 10.3109/14653249.2010.523958. Cytotherapy. 2010. PMID: 20942603

5

Allogeneic mesenchymal stem cells do not protect NZBxNZW F1 mice from developing lupus disease.

Youd M, Blickarz C, Woodworth L, Touzjian T, Edling A, Tedstone J, Ruzek M, Tubo R, Kaplan J, Lodie T. Youd M, et al. Among authors: lodie t. Clin Exp Immunol. 2010 Jul 1;161(1):176-86. doi: 10.1111/j.1365-2249.2010.04158.x. Epub 2010 Apr 29. Clin Exp Immunol. 2010. PMID: 20456409 Free PMC article.

6

Systematic analysis of reportedly distinct populations of multipotent bone marrow-derived stem cells reveals a lack of distinction.

Lodie TA, Blickarz CE, Devarakonda TJ, He C, Dash AB, Clarke J, Gleneck K, Shihabuddin L, Tubo R. Lodie TA, et al. Tissue Eng. 2002 Oct;8(5):739-51. doi: 10.1089/10763270260424105. Tissue Eng. 2002. PMID: 12459053

7

CCAAT/Enhancer binding proteins repress the leukemic phenotype of acute myeloid leukemia.

Truong BT, Lee YJ, Lodie TA, Park DJ, Perrotti D, Watanabe N, Koeffler HP, Nakajima H, Tenen DG, Kogan SC. Truong BT, et al. Among authors: lodie ta. Blood. 2003 Feb 1;101(3):1141-8. doi: 10.1182/blood-2002-05-1374. Epub 2002 Oct 3. Blood. 2003. PMID: 12393450 Free article.

8

c-Myc is a critical target for c/EBPalpha in granulopoiesis.

Johansen LM, Iwama A, Lodie TA, Sasaki K, Felsher DW, Golub TR, Tenen DG. Johansen LM, et al. Among authors: lodie ta. Mol Cell Biol. 2001 Jun;21(11):3789-806. doi: 10.1128/MCB.21.11.3789-3806.2001. Mol Cell Biol. 2001. PMID: 11340171 Free PMC article.

9

Secretory interleukin-1 receptor antagonist gene expression requires both a PU.1 and a novel composite NF-kappaB/PU.1/ GA-binding protein binding site.

Smith MF Jr, Carl VS, Lodie T, Fenton MJ. Smith MF Jr, et al. Among authors: lodie t. J Biol Chem. 1998 Sep 11;273(37):24272-9. doi: 10.1074/jbc.273.37.24272. J Biol Chem. 1998. PMID: 9727052 Free article.

10

Both PU.1 and nuclear factor-kappa B mediate lipopolysaccharide- induced HIV-1 long terminal repeat transcription in macrophages.

Lodie TA, Reiner M, Coniglio S, Viglianti G, Fenton MJ. Lodie TA, et al. J Immunol. 1998 Jul 1;161(1):268-76. J Immunol. 1998. PMID: 9647233

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

11 results

Search Page